Amyotrophic lateral sclerosis established as a multistep process across phenotypes.

IF 4.5 2区 医学 Q1 CLINICAL NEUROLOGY European Journal of Neurology Pub Date : 2024-10-30 DOI:10.1111/ene.16532
Laura Ziser, Ruben P A van Eijk, Matthew C Kiernan, Allan McRae, Robert D Henderson, David Schultz, Merrilee Needham, Susan Mathers, Pam McCombe, Paul Talman, Steve Vucic
{"title":"Amyotrophic lateral sclerosis established as a multistep process across phenotypes.","authors":"Laura Ziser, Ruben P A van Eijk, Matthew C Kiernan, Allan McRae, Robert D Henderson, David Schultz, Merrilee Needham, Susan Mathers, Pam McCombe, Paul Talman, Steve Vucic","doi":"10.1111/ene.16532","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Given the accepted multistep process of disease causation in amyotrophic lateral sclerosis (ALS), the present study was undertaken to determine the number of steps required for disease onset across each of the ALS phenotypes.</p><p><strong>Methods: </strong>Clinical and demographic data were prospectively accumulated using the Australian Motor Neurone Disease Registry (2005-2016), and age-specific incidence rates were calculated. Poisson regression was utilized to assess the relationship between log age-specific incidence and log age of onset, with McFadden's R<sup>2</sup> used to assess the goodness of fit of the model.</p><p><strong>Results: </strong>In total, 2647 ALS patients were included, with mean disease-onset age being 62.2 ± 12.1 years. A linear relationship between log incidence and log age was established across ALS phenotypes, with variable slope estimates: bulbar 5.1 (95% confidence interval [CI] 4.6-5.6); cervical 2.7 (95% CI 2.3-3.0); lumbar 3.5 (95% CI 3.2-3.9); flail arm 4.7 (95% CI 3.9-5.5); flail leg 3.6 (95% CI 2.6-4.5); primary lateral sclerosis 2.7 (95% CI 1.8-3.7). Slope estimates were significantly higher in the bulbar compared to the cervical, lumbar and primary lateral sclerosis phenotypes. McFadden's R<sup>2</sup> values were >0.4 for all phenotypes indicating excellent model fit.</p><p><strong>Discussion: </strong>A multistep process has been established across all ALS phenotypes with variable slope estimates, suggesting that the number of steps to develop disease is different across clinical presentations. Identification of mechanisms underlying slope estimate variability could exert pathophysiological significance.</p>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":" ","pages":"e16532"},"PeriodicalIF":4.5000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ene.16532","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Given the accepted multistep process of disease causation in amyotrophic lateral sclerosis (ALS), the present study was undertaken to determine the number of steps required for disease onset across each of the ALS phenotypes.

Methods: Clinical and demographic data were prospectively accumulated using the Australian Motor Neurone Disease Registry (2005-2016), and age-specific incidence rates were calculated. Poisson regression was utilized to assess the relationship between log age-specific incidence and log age of onset, with McFadden's R2 used to assess the goodness of fit of the model.

Results: In total, 2647 ALS patients were included, with mean disease-onset age being 62.2 ± 12.1 years. A linear relationship between log incidence and log age was established across ALS phenotypes, with variable slope estimates: bulbar 5.1 (95% confidence interval [CI] 4.6-5.6); cervical 2.7 (95% CI 2.3-3.0); lumbar 3.5 (95% CI 3.2-3.9); flail arm 4.7 (95% CI 3.9-5.5); flail leg 3.6 (95% CI 2.6-4.5); primary lateral sclerosis 2.7 (95% CI 1.8-3.7). Slope estimates were significantly higher in the bulbar compared to the cervical, lumbar and primary lateral sclerosis phenotypes. McFadden's R2 values were >0.4 for all phenotypes indicating excellent model fit.

Discussion: A multistep process has been established across all ALS phenotypes with variable slope estimates, suggesting that the number of steps to develop disease is different across clinical presentations. Identification of mechanisms underlying slope estimate variability could exert pathophysiological significance.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肌萎缩性脊髓侧索硬化症是一个跨表型的多步骤过程。
背景和目的:鉴于肌萎缩性脊髓侧索硬化症(ALS)的致病过程具有公认的多步骤性,本研究旨在确定每种 ALS 表型发病所需的步骤数量:通过澳大利亚运动神经元疾病登记处(2005-2016 年)前瞻性地积累了临床和人口统计学数据,并计算了特定年龄的发病率。利用泊松回归评估对数年龄特异性发病率与对数发病年龄之间的关系,并利用麦克法登 R2 评估模型的拟合度:共纳入了 2647 例 ALS 患者,平均发病年龄为 62.2 ± 12.1 岁。不同 ALS 表型的对数发病率与对数年龄之间呈线性关系,斜率估计值各不相同:球部 5.1(95% 置信区间 [CI] 4.6-5.6);颈部 2.7(95% CI 2.3-3.0);腰部 3.5(95% CI 3.2-3.9);手臂外翻 4.7(95% CI 3.9-5.5);腿部外翻 3.6(95% CI 2.6-4.5);原发性侧索硬化 2.7(95% CI 1.8-3.7)。与颈椎病、腰椎病和原发性侧索硬化症表型相比,球部病变的斜率估计值明显较高。所有表型的麦克法登 R2 值均大于 0.4,表明模型拟合度极佳:讨论:所有 ALS 表型都有一个多步骤过程,但斜率估计值各不相同,这表明不同临床表现的疾病发展步骤数量不同。确定斜率估计值可变性的内在机制可能具有重要的病理生理学意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Neurology
European Journal of Neurology 医学-临床神经学
CiteScore
9.70
自引率
2.00%
发文量
418
审稿时长
1 months
期刊介绍: The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).
期刊最新文献
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis. Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial. Real-life experience with disease-modifying drugs in hereditary transthyretin amyloid polyneuropathy: A clinical and electrophysiological appraisal. Switching from ligand to receptor anti-calcitonin gene-related peptide (CGRP) antibodies or vice versa in non-responders: A controlled cohort study. Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1